Ronan J. Mahon

Gaillimh, C, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Recommendations for the use of early cost-effectiveness analysis to inform the health technology development process with an application to cutaneous squamous cell carcinoma.

Recommendations for the use of early cost-effectiveness analysis to inform the health technology development process with an application to cutaneous squamous cell carcinoma.

Journal: International journal of technology assessment in health care

Published: December 12, 2025

The costs and benefits of an early access scheme for oncology medicines in Ireland.

The costs and benefits of an early access scheme for oncology medicines in Ireland.

Journal: BMC health services research

Published: October 30, 2025

Applications of Artificial Intelligence as a Prognostic Tool in the Management of Acute Aortic Syndrome and Aneurysm: A Comprehensive Review.

Applications of Artificial Intelligence as a Prognostic Tool in the Management of Acute Aortic Syndrome and Aneurysm: A Comprehensive Review.

Journal: Journal of clinical medicine

Published: September 17, 2025

Looking back to move forward: can historical clinical trial data and machine learning drive change in participant recruitment in anticipation of future value assessments?

Looking back to move forward: can historical clinical trial data and machine learning drive change in participant recruitment in anticipation of future value assessments?

Journal: Trials

Published: May 23, 2025

Implications of Incorporating Environmental Sustainability Into Health Technology Assessment for Digital Health Technologies.

Implications of Incorporating Environmental Sustainability Into Health Technology Assessment for Digital Health Technologies.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: May 14, 2025

Implications of Incorporating Environmental Sustainability into HTA for Digital Health Technologies.

Implications of Incorporating Environmental Sustainability into HTA for Digital Health Technologies.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: May 14, 2025

Cost effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE)-A randomised placebo-controlled clinical trial.

Cost effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE)-A randomised placebo-controlled clinical trial.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: October 25, 2024

Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison.

Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison.

Journal: Journal of comparative effectiveness research

Published: January 04, 2024

Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine.

Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine.

Journal: Current medical research and opinion

Published: October 03, 2022

Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden.

Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden.

Journal: PharmacoEconomics

Published: December 24, 2020

Economic evaluations in migraine: systematic literature review and a novel approach.

Economic evaluations in migraine: systematic literature review and a novel approach.

Journal: Journal of medical economics

Published: April 15, 2020

Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach.

Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach.

Journal: International journal of chronic obstructive pulmonary disease

Published: January 24, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026